Novy, E., Rivière, J., Nguyen, M., Arfeuille, G., Louis, G., Bouhemad, B., . . . Guerci, P. (2023). Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients. Critical Care, 27(1), . https://doi.org/10.1186/s13054-023-04761-7
Chicago-referens (17:e uppl.)Novy, Emmanuel, et al. "Combination of Serum and Peritoneal 1.3-beta-d-glucan Can Rule Out Intra-abdominal Candidiasis in Surgical Critically Ill Patients." Critical Care 27, no. 1 (2023). https://doi.org/10.1186/s13054-023-04761-7.
MLA-referens (9:e uppl.)Novy, Emmanuel, et al. "Combination of Serum and Peritoneal 1.3-beta-d-glucan Can Rule Out Intra-abdominal Candidiasis in Surgical Critically Ill Patients." Critical Care, vol. 27, no. 1, 2023, https://doi.org/10.1186/s13054-023-04761-7.
